| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |